Icahn School of Medicine at Mount Sinai is one of more than 800 institutions with graduate schools surveyed by U.S. News on an annual basis. Icahn School of Medicine at Mount Sinai confers degrees ...

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

Dr. Jessica Lichter, Assistant Professor and academic hospitalist at Elmhurst Hospital, part of the New York City Health + ...

Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...

"Our research reveals the potential for digenic inheritance—where two genes work together to cause disease—expanding our ...

In the past, Dr. Horowitz had been a paid consultant for Purple Biotech.

Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Forbes does not accept payment for placement on lists. This company paid for expanded information and features to appear on their Forbes Profile. For more information, click here. The mission of ...

Do you work at Icahn School of Medicine at Mount Sinai? Manage your school's public image and connection with students using U.S. News Student Connect.

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that ...

announced today that it has entered into a Research Collaboration Agreement with the Icahn School of Medicine at Mount Sinai (“Icahn School of Medicine”) in New York, NY, to explore the ...